The Waltham, Mass.-based company said that Cowen and Company will serve as its sales agent in the sale, but has not stated how many shares or other details of the offering yet.
The round will be an “at the market” offering through Cowen and Corindus said it may reimburse Cowen up to a maximum of $62,500 for expenses related to the offering, according to an SEC filing.
In May, Corindus saw shares fall after the robotic-surgery platform maker missed sales expectations on Wall Street with its first quarter 2018 earnings results.
Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.
At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!
Use code WOMENSHEALTH to save an additional 10%.